Episode 220: Historic Agreement on GLP-1 Obesity Medication
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
-
Narrado por:
-
De:
In this powerful episode, I will break down one of the biggest developments in obesity and diabetes treatment in U.S. history.
Two major pharmaceutical companies - Eli Lilly and Novo Nordisk - have reached a groundbreaking agreement with the administration that will drastically reduce the prices of popular medications like Wegovy, Ozempic, and Zepbound. This pricing model could transform how obesity medications are covered, distributed, and accessed across Medicare, Medicaid, and direct-to-consumer platforms.
Tune in to learn what this new deal means for patients, healthcare providers, and public health overall—and why it's being called a game changer for people struggling with obesity and related health conditions.
Episode Highlights:
-
Major price cuts announced for Wegovy, Ozempic, and Zepbound under a new federal deal
-
Medicare to cover obesity drugs for the first time through a five-year pilot program
-
Medicaid given the option to join discounted pricing starting 2026
-
Team Rx launches a direct-to-consumer model cutting out costly middlemen
-
Lower cash prices for GLP-1 medications and upcoming oral versions
-
Eli Lilly and Novo Nordisk to invest billions in U.S. manufacturing
-
Program expected to improve access, affordability, and supply of obesity and diabetes meds
-
Ongoing push for the Treat and Reduce Obesity Act to expand national coverage
Connect with Dr. Alicia Shelly:
-
Website | drshellymd.com
-
Facebook | www.facebook.com/drshellymd
-
Instagram | @drshellymd
-
Linked In | www.linkedin.com/in/drshellymd
-
Twitter | @drshellymd
About Dr. Alicia Shelly
Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH. Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014. In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss, where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, "Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.
Resources:
FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!) 👉 Click